COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome (MUST-ARDS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02611609
Recruitment Status : Completed
First Posted : November 23, 2015
Last Update Posted : November 20, 2019
Athersys Limited
Cell Therapy Catapult
Information provided by (Responsible Party):
Athersys, Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2018
Actual Study Completion Date : July 2019
Certification/Extension First Submitted : November 12, 2019